Cite
HARVARD Citation
Shainheit, M. et al. (n.d.). 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors. Journal for immunotherapy of cancer. p. A438. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shainheit, M. et al. (n.d.). 413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors. Journal for immunotherapy of cancer. p. A438. [Online].